There	EX	O
are	VBP	O
conflicting	VBG	B
studies	NNS	I
,	,	O
and	CC	O
it	PRP	O
is	VBZ	O
unclear	JJ	B
if	IN	O
phytoestrogens	NNS	O
have	VBP	O
any	DT	O
effect	NN	O
on	IN	O
the	DT	O
cause	NN	O
or	CC	O
prevention	NN	O
of	IN	O
cancer	NN	O
in	IN	O
females	NNS	O
.	.	O
Epidemiological	JJ	O
studies	NNS	O
showed	VBD	O
a	DT	O
protective	JJ	O
effect	NN	O
against	IN	O
breast	NN	O
cancer	NN	O
.	.	O
'	``	O
In	IN	O
vitro	FW	O
'	''	O
studies	NNS	O
concluded	VBD	O
that	IN	O
females	NNS	O
with	IN	O
current	JJ	O
or	CC	O
past	JJ	O
breast	NN	O
cancer	NN	O
should	MD	O
be	VB	O
aware	JJ	O
of	IN	O
the	DT	O
risks	NNS	O
of	IN	O
potential	JJ	O
tumor	NN	O
growth	NN	O
when	WRB	O
taking	VBG	O
soy	NN	O
products	NNS	O
,	,	O
as	IN	O
they	PRP	O
can	MD	O
stimulate	VB	O
the	DT	O
growth	NN	O
of	IN	O
estrogen	NN	O
receptor	NN	O
-	HYPH	O
positive	JJ	O
cells	NNS	O
in	IN	O
vitro	NN	O
.	.	O
A	DT	O
2006	CD	O
review	NN	O
article	NN	O
stated	VBD	O
the	DT	O
opinion	NN	O
that	IN	O
not	RB	O
enough	JJ	O
information	NN	O
is	VBZ	O
available	JJ	O
,	,	O
and	CC	O
that	IN	O
even	RB	O
if	IN	O
isoflavones	NNS	O
have	VBP	O
mechanisms	NNS	O
to	TO	O
inhibit	VB	O
tumor	NN	O
growth	NN	O
,	,	O
'	''	O
in	IN	O
vitro	FW	O
'	''	O
results	NNS	O
justify	VBP	O
the	DT	O
need	NN	O
to	TO	O
evaluate	VB	O
,	,	O
at	IN	O
cellular	JJ	O
level	NN	O
,	,	O
the	DT	O
impact	NN	O
of	IN	O
isoflavones	NNS	O
on	IN	O
breast	NN	O
tissue	NN	O
in	IN	O
females	NNS	O
at	IN	O
high	JJ	O
risk	NN	O
for	IN	O
breast	NN	O
cancer	NN	O
.	.	O
The	DT	O
generally	RB	B
accepted	VBN	I
position	NN	O
on	IN	O
this	DT	O
topic	NN	O
is	VBZ	O
that	IN	O
phytoestrogens	NNS	O
may	MD	B
be	VB	O
beneficial	JJ	O
for	IN	O
healthy	JJ	O
females	NNS	O
and	CC	O
that	IN	O
females	NNS	O
with	IN	O
known	VBN	O
breast	NN	O
cancer	NN	O
should	MD	O
be	VB	O
aware	JJ	O
of	IN	O
potential	JJ	O
risks	NNS	O
and	CC	O
consider	VB	O
avoiding	VBG	O
consumption	NN	O
until	IN	O
more	JJR	O
information	NN	O
is	VBZ	O
available	JJ	O
.	.	O
